Asia

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

Latest Asia Analysis

Industry Trend Analysis - Trump's Policies To Affect The Development Of Region's Pharmaceutical Sectors - APR 2017

Acts undertaken by US President Donald Trump will shape the Asia Pacific's pharmaceutical sectors. The withdrawal of the US from the Trans-Pacific Partnership is particularly significant, passing up an opportunity to introduce strong intellectual property protections which would have had ramifications beyond the original seven Asia Pacific member states. Trump's push to encourage the domestic...

READ FULL ARTICLE...

Industry Trend Analysis - Failure To Ratify TPP To Be A Loss For Innovative Pharmaceutical Firms - MAR 2017

A failure to ratify the Trans-Pacific Partnership (TPP) will be a negative for multinational drugmakers operating in the Asia Pacific. With seven of the 12 participating members in the APAC region, collectively accounting for 42% of the region's medicine sales in 2016, the trade deal would have altered the landscape by introducing stronger intellectual property protection among other measures. ...

READ FULL ARTICLE...